Nitrous oxide and serious morbidity and mortality in the POISE trial

Kate Leslie1, Paul Myles, Philip J Devereaux

  • 1From the Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne; Department of Pharmacology, University of Melbourne, Melbourne; Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne; Academic Board of Anaesthesia and Perioperative Medicine, Monash University, Melbourne, Australia; Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; School of Population Health, University of Melbourne, Melbourne, Australia; Fu Wai Cardiovascular Hospital, CAMS, Beijing, Peoples Republic of China; Nuffield Division of Anaesthetics, Oxford University, Oxford, United Kingdom; Nueva Granada Military University, Bogota; Department of Anaesthesia, Resuscitation and Pain Management, Central Military Hospital, Bogota, Colombia; Department of Anesthesiology, The Ottawa Hospital, Ottawa, Ontario; Department of Anesthesia, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada; School of Medicine and Pharmacology, University of Western Australia, Perth; Department of Anaesthesia and Pain Medicine, King Edward Memorial Hospital for Women, Perth, Australia; Department of Anesthesia and Perioperative Medicine, Royal Columbian Hospital, New Westminster, British Columbia; Department of Anesthesiology, the University of British Columbia, Vancouver, British Columbia; Department of Anesthesia, Perioperative Medicine, University of Western Ontario, London, Ontario, Canada; Department of Anaesthesia, Department of Surgery, Austin Hospital and University of Melbourne, Melbourne, Australia; Nuffield Department of Anaesthetics, Oxford University, Oxford, United Kingdom; and Department of Anesthesia, University of Ottawa, Ottawa, Ontario, Canada.

Anesthesia and Analgesia
|January 23, 2013
PubMed
Abstract

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...